Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
8/17/26 AstraZeneca (AZN) Orpathys for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only
8/17/26 AstraZeneca (AZN) Tagrisso for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only
8/10/26 Sionna Therapeutics (SION) SION‑719 for Cystic Fibrosis (CF) Subscribers Only Subscribers Only Subscribers Only
8/6/26 Agenus (AGEN) agenT-797 for Pneumococcal (Streptococcus pneumoniae) Vaccines Subscribers Only Subscribers Only Subscribers Only
8/6/26 Agenus (AGEN) agenT-797 for Acute Respiratory Failure, Acute Lung Injury (ALI), Acute Respiratory Distress Syndrome (ARDS) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/26/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/08/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/17/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update